CELLECT BIOTECH / S (APOP) gets a daily impact score of 0.10

Business



[ad_1]

CELLECT BIOTECH / S logo "title =" CELLECT BIOTECH / S logo "clbad =" companylogo "/> Media titles on CELLECT BIOTECH / S (NASDAQ: APOP) have evolved somewhat positive recently, according to Accern Sentiment. The company identifies in real time over twenty million news and sources of real-time blogs. Accern ranks the coverage of publicly traded companies on a scale of -1 to 1, the closest scores to the company. 39; one being the most favorable CELLECT BIOTECH Accern also scored an opinion score of 0.10 on the Accern.Accern scale also gave newspapers an impact score of 45.3730826057056 out of 100, which means that coverage of recent news is unlikely to have an effect on the stock price </p> <p> APOP stock fell 0, $ 21 during Friday trading hours, reaching $ 6.49 The stock had a trading volume of 117 5 55 shares, compared to its average volume of 9,493. CELLECT BIOTECH / S has a low of $ 5. 92 and a high of $ 13.50 in one year. </p> <p> CELLECT BIOTECH / S (NASDAQ: APOP) released its results on Thursday 17 May. The company reported earnings per share of $ 0.16 for the quarter, exceeding the consensus estimate of Thomson Reuters by $ 0.14 ($ 0.30). Sell ​​side badysts predict that CELLECT BIOTECH / S will show -1 earnings per share for the current year. </p> <p> A number of research badysts have published reports on APOP actions. HC Wainwright set a target price of $ 14.00 on CELLECT BIOTECH / S and awarded the company a "buy" rating in a research note on Monday, July 16th. ValuEngine raised CELLECT BIOTECH / S from a "sell" rating to a "keep" rating in a research note on Wednesday, June 6th. Finally, Zacks Investment Research upgraded CELLECT BIOTECH / S from a "hold" rating to a "buy" rating and set a price target of $ 8.25 for the company in a research report on Thursday, May 31 . </p> <p> <strong> About CELLECT BIOTECH / S </strong> </p> <p> Cellect Biotechnology Ltd., a biotechnology company, focuses on the development of technologies for the functional selection of stem cells in the field of regenerative medicine and stem cell therapies in Israel. It develops the Apotainer Selection Kit, a stem cell selection kit on the shelf, based on its Powered by Cellect technology platform for allogeneic hematopoietic stem cell transplantation procedures for patients with hematological malignancies.Read more : What are the different types of Leveraged <!--ViewCount:type=m&id=481036--></p> <p style= Buying and selling insiders by quarter for CELLECT BIOTECH / S (NASDAQ: APOP)

Receive the news of CELLECT BIOTECH / S per day – Enter your email address below to receive a concise daily summary of the latest news and badyst ratings for CELLECT BIOTECH / S and related companies with MarketBeat.com's free daily newsletter.

[ad_2]
Source link

Tags

Powered by https://naaju.com/israel | Designed by Naaju
© Copyright 2024, All Rights Reserved